|
Health Briefs
May
16, 2002
by Robert A. Wascher, M.D., F.A.C.S.
ETHNIC DIFFERENCES IN DIABETIC COMPLICATIONS
Inadequate access to medical care has been cited as the primary explanation
for the poorer outcomes that ethnic minorities with certain diseases often
experience.
In this week’s Journal of the American
Medical Association (JAMA), 62,432 diabetic patients enrolled in a
large HMO were longitudinally studied for a period of four years. Caucasians
made up 64% of the study population, while 14% of patients were Black,
12% were Asian, and 10% were Latino. As all patients, irrespective of
their ethnic background, presumably had equal access to care, this study
sought to evaluate intrinsic ethnicity-related factors that might affect
the incidence of complications due to diabetes.
Interestingly, the Caucasian diabetic
patients experienced, on the average, a higher incidence of heart attack
and stroke than did any of the minority group patients. However, the risk
of developing kidney failure was 1.5 to 2 times as high among the minority
group patients when compared to Caucasian patients.
The authors, therefore, concluded that
access to care may not be the only issue that impacts upon diverse disease
outcomes between different ethnic groups.
This large study’s results point to a
probable genetic variation in responses to diabetes among people of different
ethnic backgrounds. The next step towards proving this hypothesis would
be to study the activation patterns of large numbers of genes in diabetics.
Comparing gene activation patterns between diabetics from different ethnic
groups may identify unique genetic characteristics that could explain
this study’s findings. Other diseases, including cardiovascular disease,
stroke, high blood pressure, obesity and cancer should be studied from
this perspective as well, as prior research has shown variation in the
incidence of -- and mortality from -- these diseases among different ethnic
groups.
MODERATE ALCOHOL INTAKE AND BLOOD SUGAR
LEVELS
Moderate alcohol intake (1 to 2 drinks per day) has been shown to reduce
the risk of coronary artery disease and stroke in a number of research
studies. There is also some evidence that moderate drinking might improve
the sensitivity of the body’s cells to insulin, the hormone that allows
cells to take-up glucose from the blood (the loss of insulin sensitivity
causes adult onset , or type II, diabetes).
This week’s JAMA contains an interesting
study that looks at the effects of moderate alcohol intake on the insulin
and glucose levels in the blood of postmenopausal women. Although the
study included only 63 women, the researchers found that 2 alcoholic drinks
per day was associated with significantly improved insulin sensitivity,
as well as reduced levels of triglycerides (a form of fat) in the blood.
Although excessive drinking has been clearly implicated in a number of
diseases, this study provides further evidence that modest-to-moderate
drinking may have important health benefits.
MORE GOOD NEWS FOR TEA DRINKERS
I recently reported on the favorable correlation between moderate tea
drinking and a reduced risk of death after heart attack. Now a new study
in the Archives of Internal Medicine suggests that regular tea drinking
may be associated with improved bone mineral density as well.
Over 1,000 men and women were queried
about their tea drinking habits, and were then tested for bone mineral
density using a sophisticated x-ray test called dual-energy x-ray absorptiometry
(DEXA scan). A total of 58% of the study participants were habitual tea
drinkers, with an average duration of tea consumption of about 10 years.
When compared to nonhabitual tea drinkers, the habitual tea drinkers had
significantly increased bone mass in the bones of the lumbar spine (a
common site of bone-thinning, or osteoporosis). Sex, age, body mass, and
level of physical activity all affected bone mass, but the habitual consumption
of tea for 10 or more years proved to be a significant and independent
factor favoring increased bone mass. In addition to containing potent
antioxidants, it appears that other components of tea might have a bone-strengthening
effect that, in theory, might reduce the risk of bone fractures due to
osteoporosis.
BLOOD POTASSIUM LEVELS & THE RISK OF
CARDIOVASCULAR DISEASE
There have been a couple of previous studies that linked variations in
blood potassium levels with an increased risk of heart disease. A new
report from the Framingham Heart Study, one of the largest and longest-running
cardiovascular health studies in the world, now strongly suggests that
there is no relationship between blood potassium levels and the risk of
heart disease. As reported in the Archives of Internal Medicine, more
than 3,000 volunteers had their blood potassium levels monitored between
1979 and 1983. Contrary to previous reports, there was no apparent increase
in cardiovascular disease-related deaths with increasing levels of potassium
in the blood.
BRIEFLY…
Post Script: As a follow-up to last week’s story on breastfeeding, I wanted
to pass along two breastfeeding resources sent to me by concerned readers.
In many cases where mothers (and first time mothers in particular) encounter
difficulties in breastfeeding their newborns, the advice and assistance
of experienced lactation experts can make all the difference in the world
between breastfeeding success and failure. The following hyperlinks should
be of interest to parents of infants who might be experiencing breastfeeding
challenges:
http://www.lalecheleague.org/WebUS.html
http://www.breastfeeding.com
ASCO
I will be attending the annual meeting of the American Society of Clinical
Oncology this week in Orlando. This is the largest annual cancer meeting
in the world, and is the premier forum for the release of cutting-edge
research in cancer-related science. I will be presenting my own research
in Orlando, and look forward to sharing important new developments with
my readers when I return next week.
Dr. Robert A. Wascher
Dr. Robert A. Wascher is
a senior research fellow in molecular & surgical oncology at the John Wayne
Cancer Institute in Santa Monica, CA
|